Umlaut.bio

Info

Decoding RNA Modifications to revolutionize cancer and inflammation treatment

Umlaut.bio GmbH is a pioneering biotech company focused on developing first-in-biology therapies targeting cancer and inflammatory diseases. Small molecules will be developed inhibiting key steps in tRNA modification thereby preventing overactivation of a multitude of signalling molecules at scale. This is a hallmark of uncontrolled cancer growth as well as autoimmune diseases which can not be addressed with chemotherapy or targeting individual proteins.